Daytrana Patch Skin Problems: Lawsuits Reviewed for Discoloration, Scaring
Following recent FDA warnings about the risk of skin problems from the Daytrana ADHD patch, the product liability lawyers at Saiontz & Kirk, P.A. are reviewing whether users who have experienced skin discoloration, scaring or disfigurement may be entitled to financial compensation through a Daytrana patch lawsuit.
Daytrana (methylphenidate transdermal system) is a medicated patch applied once per day for the treatment of attention deficit and hyperactivity disorder (ADHD). It was originally approved by the FDA in 2006, and has been plagued with problems and Daytrana recalls.
Learn More About a Daytrana Patch Lawsuit
Following reports of users experiencing loss of skin pigmentation, the FDA issued a drug safety communication last month warning about a risk of chemical leukoderma from Daytrana side effects.
This potential side effect of Daytrana may cause individuals to experience:
- Changes to Skin Color
- Complete Loss of Skin Pigmentation
- Light or White Patches of Skin
While chemical leukoderma does not cause any physical harm, it usually results in permanent scarring or disfigurement, which can cause severe embarrassment, emotional distress or otherwise impact an individuals self-image or quality of life.
Daytrana Chemical Leukoderma Warnings
The FDA indicates that all reported cases of chemical leukoderma from Daytrana have been permanent, resulting in lost pigmentation that stretched up to eight inches across for some users.
While most of the Daytrana skin patch problems appeared where the ADHD patch was regularly applied or rotated, in some cases the lost skin color developed elsewhere on the body. The problem can appear as soon as a few months after first Daytrana patch use, or can wait several years to appear.
Prior to the recent label change announced by the FDA, it appears that the Daytrana patch warnings failed to adequately warn users and the medical community about the risk of these permanent and disfiguring side effects, which may impact children or adults using the ADHD skin patch.
It appears likely that most users would have elected not to wear the Daytrana patch for ADHD if they had been aware of the risk of permanently disfiguring skin problems, as many other treatment options are available for the condition.
Daytrana Patch Class Action Lawyers
The Daytrana lawyers at Saiontz & Kirk, P.A. are reviewing individual chemical leukoderma lawsuits, as well as potential Daytrana class action lawsuits as a result of the drug maker’s failure to adequately warn about the risk of skin problems.
It appears that the manufacturers may have placed their desire for profits before consumer safety, exposing individuals to a risk of severe skin problems from Daytrana that could have been avoided if adequate warnings had been provided.
To submit information about scarring or skin color changes that may have been caused by Daytrana patch side effects, request a free consultation and claim evaluation.